Back to Search
Start Over
Addition of apatorsen, an inhibitor of Hsp27, to first-line gemcitabine/carboplatin in advanced squamous cell lung cancer: Design of the Cedar study
- Source :
- ResearcherID, Web of Science
- Publication Year :
- 2015
- Publisher :
- American Society of Clinical Oncology (ASCO), 2015.
-
Abstract
- TPS8111 Background: Outcomes remain poor in patients with non-small cell lung cancer (NSCLC) of squamous origin. There are few established therapeutic targets, and benefits of chemotherapy are freq...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Chemotherapy
biology
business.industry
medicine.medical_treatment
First line
Squamous cell lung cancer
Carboplatin
Gemcitabine
respiratory tract diseases
chemistry.chemical_compound
chemistry
Hsp27
Internal medicine
biology.protein
Medicine
In patient
Non small cell
business
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi.dedup.....62de8190f84a194c3876500c84c321e3
- Full Text :
- https://doi.org/10.1200/jco.2015.33.15_suppl.tps8111